132 related articles for article (PubMed ID: 19593614)
21. Moderate neutropenia with S-1 plus low-dose cisplatin may predict a more favourable prognosis in advanced gastric cancer.
Nakata B; Tsuji A; Mitachi Y; Yamamitsu S; Hirata K; Takeuchi T; Shirasaka T; Hirakawa K
Clin Oncol (R Coll Radiol); 2006 Nov; 18(9):678-83. PubMed ID: 17100153
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of target combined chemotherapy in advanced gastric cancer: a meta-analysis and system review.
Zou K; Yang S; Zheng L; Yang C; Xiong B
BMC Cancer; 2016 Sep; 16(1):737. PubMed ID: 27633381
[TBL] [Abstract][Full Text] [Related]
23. Clinical significance of adjuvant surgery following chemotherapy for patients with initially unresectable stage IV gastric cancer.
Ito S; Oki E; Nakashima Y; Ando K; Hiyoshi Y; Ohgaki K; Saeki H; Morita M; Sakaguchi Y; Maehara Y
Anticancer Res; 2015 Jan; 35(1):401-6. PubMed ID: 25550579
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of intraperitoneal and intravenous chemotherapy and left upper abdominal evisceration for advanced gastric cancer.
Nomura E; Niki M; Fujii K; Shinohara H; Nishiguchi K; Sonoda T; Tanigawa N
Gastric Cancer; 2001; 4(2):75-82. PubMed ID: 11706764
[TBL] [Abstract][Full Text] [Related]
25. Postoperative chemotherapy may improve prognosis in unresectable gastric cancer.
Hanazaki K; Sodeyama H; Yokoyama S; Sode Y; Wakabayashi M; Kawamura N; Miyazaki T; Otsuka M
J Clin Gastroenterol; 1998 Jun; 26(4):269-73. PubMed ID: 9649009
[TBL] [Abstract][Full Text] [Related]
26. Retrospective comparison of infusional 5-fluorouracil, doxorubicin, and mitomycin-C (modified FAM) combination chemotherapy versus palliative therapy in treatment of advanced gastric cancer.
Park JO; Chung HC; Cho JY; Rha SY; You NC; Kim JH; Noh SH; Kim CB; Min JS; Kim BS; Roh JK
Am J Clin Oncol; 1997 Oct; 20(5):484-9. PubMed ID: 9345333
[TBL] [Abstract][Full Text] [Related]
27. Chemoresponse after non-curative gastrectomy for M1 gastric cancer.
Shin HB; Lee SH; Son YG; Ryu SW; Sohn SS
World J Surg Oncol; 2015 Jan; 13():13. PubMed ID: 25634223
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of preoperative chemotherapy regimens in patients with initially unresectable locally advanced gastric adenocarcinoma: capecitabine and oxaliplatin (XELOX) or with epirubicin (EOX).
Wang Y; Zhuang RY; Yu YY; Yu S; Hou J; Ji Y; Sun YH; Shen KT; Shen ZB; Liu FL; Zhao NQ; Liu TS
Oncotarget; 2016 Nov; 7(46):76298-76307. PubMed ID: 27602586
[TBL] [Abstract][Full Text] [Related]
29. Results of immunochemo-surgery for gastric carcinoma.
Kim JP; Yu HJ; Lee JH
Hepatogastroenterology; 2001; 48(41):1227-30. PubMed ID: 11677936
[TBL] [Abstract][Full Text] [Related]
30. [Clinical results of single therapy with TS-1 for advanced/recurrent gastric cancer].
Ohshima T; Yamada R; Hatori S; Kunisaki C; Makino T; Yamazaki Y; Suda T; Rino Y; Takanashi Y; Imada T
Gan To Kagaku Ryoho; 2006 Aug; 33(8):1105-10. PubMed ID: 16912529
[TBL] [Abstract][Full Text] [Related]
31. Ten-year survival of curability B gastric cancer patients treated by tegafur-uracil as postoperative adjuvant chemotherapy in a common public hospital: univariate and multivariate analyses.
Okuyama T; Higashi T; Edagawa A; Nagata S; Hashimoto K; Saeki H; Oki E; Uchiyama H; Kawanaka H; Morita M; Tateishi M; Korenaga D; Yaita H; Takenaka K
Fukuoka Igaku Zasshi; 2012 Jul; 103(7):138-44. PubMed ID: 22978066
[TBL] [Abstract][Full Text] [Related]
32. Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial.
Fujitani K; Yang HK; Mizusawa J; Kim YW; Terashima M; Han SU; Iwasaki Y; Hyung WJ; Takagane A; Park DJ; Yoshikawa T; Hahn S; Nakamura K; Park CH; Kurokawa Y; Bang YJ; Park BJ; Sasako M; Tsujinaka T;
Lancet Oncol; 2016 Mar; 17(3):309-318. PubMed ID: 26822397
[TBL] [Abstract][Full Text] [Related]
33. [The Clinical Outcome of Conversion Surgery for Unresectable Gastric Cancers in Our Institution].
Gunji H; Sakuramoto S; Aratani K; Chuman M; Wakata M; Miyawaki Y; Sato H; Okamoto K; Yamaguchi S; Koyama I
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1458-1460. PubMed ID: 29394667
[TBL] [Abstract][Full Text] [Related]
34. [Safety and effectiveness of oxaliplatin combined with capecitabine or oxaliplatin combined with S-1 neoadjuvant chemotherapy in the treatment of advanced gastric cancer].
Xie BW; Zang L; Ma JJ; Sun J; Yang X; Wang ML; Lu AG; Hu WG; Zheng MH
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):138-144. PubMed ID: 33508919
[No Abstract] [Full Text] [Related]
35. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
[No Abstract] [Full Text] [Related]
36. Long-term survival and prognostic factors in patients with metastatic gastric cancers treated with chemotherapy in the Japan Clinical Oncology Group (JCOG) study.
Yoshida M; Ohtsu A; Boku N; Miyata Y; Shirao K; Shimada Y; Hyodo I; Koizumi W; Kurihara M; Yoshida S; Yamamoto S
Jpn J Clin Oncol; 2004 Nov; 34(11):654-9. PubMed ID: 15613554
[TBL] [Abstract][Full Text] [Related]
37. [Chemotherapy for patients with advanced/recurrent gastric cancer and the practice at our institute].
Kishimoto T; Imamura H; Furukawa H; Yamamoto K; Tatsuta M
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1682-4. PubMed ID: 16315908
[TBL] [Abstract][Full Text] [Related]
38. [Evaluation of neoadjuvant chemotherapy with paclitaxel, 5-fluorouracil and cisplatin for advanced gastric cancer with pyloric stenosis].
Yamaguchi K; Nakagawa S; Yabusaki H; Nashimoto A
Gan To Kagaku Ryoho; 2007 Dec; 34(13):2241-4. PubMed ID: 18079622
[TBL] [Abstract][Full Text] [Related]
39. [Comparison of the efficacy and safety of capecitabine or tegafur, gimeracil and oteracil potassium capsules combined with oxaliplatin chemotherapy regimens in the treatment of advanced gastric cancer].
Wan Y; Hui H; Wang X; Wu J; Sun S
Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):28-34. PubMed ID: 26796803
[TBL] [Abstract][Full Text] [Related]
40. A retrospective study of the safety and efficacy of a first-line treatment with modified FOLFOX-4 in unresectable advanced or recurrent gastric cancer patients.
Yeh YS; Tsai HL; Ma CJ; Wu DC; Lu CY; Wu IC; Hou MF; Wang JY
Chemotherapy; 2012; 58(5):411-8. PubMed ID: 23306825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
